MYX.L

MyCelx Technologies Corporation (DI)
MyCelx Tech. Corp. - EPA Publishes National Drinking Water Standards
11th April 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 1096K
MyCelx Technologies Corporation
11 April 2024
 

11 April 2024

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

EPA Publishes National Drinking Water Standards

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company transforming the environmental impact of industry, notes the announcement by the United States Environmental Protection Agency ("EPA") regarding the first-ever national, legally enforceable drinking water standards for PFAS exposure.

 

MYCELX notes that the EPA has announced the first-ever national, legally enforceable drinking water standard to protect communities from exposure to harmful PFAS substances known as "forever chemicals". PFAS exposure has been linked to several cancers, liver and heart issues, and immune and developmental damage to infants and children. The final rule will reduce PFAS exposure for approximately 100 million people, preventing deaths and reducing serious illnesses. There will be circa $1 billion in newly available funding through the Bipartisan Infrastructure Law to help states and territories implement PFAS testing and treatment at public water systems and to help owners of private wells address PFAS contamination in addition to a $9 billion investment to help communities with drinking water impacted by PFAS and other emerging contaminants.

 

More details can be found at the following link: https://www.epa.gov/newsreleases/biden-harris-administration-finalizes-first-ever-national-drinking-water-standard

 

Connie Mixon, CEO, commented:

 

"We are very pleased to see this announcement by the EPA. The need for successful treatment of "forever chemicals" is now acknowledged and funding is being made available which will accelerate the adoption of new and more effective technology such as ours.    MYCELX is engaged and very focused on the PFAS remediation market, as the Company's unique and patented technology is proven to successfully treat water and remediate sites that have been contaminated by PFAS chemicals, up to current EPA water standards."

 

For further information, please contact: 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity Limited (Nomad and Sole Broker)

Henry Fitzgerald-O'Connor

Ana Ercegovic

 

 

Tel: +44 20 7523 8000

Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

Charlie Denley-Myerson

 

Tel: +44 20 7770 6424

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAVBLFFZZLZBBE]]>
TwitterFacebookLinkedIn